ATX-101: Clinical Trials

6 trials of ATX-101, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated. 6 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 4, Terminated 2
Phase 11Completed 1

Follow ATX-101: new trials by email Literature Review of ATX-101 trials Research Report on ATX-101

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Assessing Pain Relief After Replacement of the Knee
ATX-101, bupivacaine hydrochloride without epinephrine - Acute Postoperative Pain
Phase 2TerminatedAllay Therapeutics, Inc.1122022-06-072025-08-14
ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma
ATX-101 - Leiomyosarcoma, Liposarcoma
Phase 2TerminatedBenjamin Izar42022-01-112023-12-06
Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study
Deoxycholic acid injection, Placebo - Moderate or Severe Submental Fullness
Phase 2CompletedKythera Biopharmaceuticals1292009-12-012015-06-15
Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat
Deoxycholic Acid Injection, Placebo - Moderate or Severe Submental Fullness
Phase 2CompletedKythera Biopharmaceuticals732008-04-012015-07-14
Phase 2 Study for the Treatment of Superficial Lipomas
Deoxycholic Acid Injection, Placebo - Lipoma
Phase 2CompletedKythera Biopharmaceuticals622007-11-012016-01-14
Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat
Deoxycholic Acid Injection, Placebo - Moderate or Severe Submental Fullness
Phase 1 / Phase 2CompletedKythera Biopharmaceuticals852007-08-012015-07-14

Conditions studied

Lymphoma, Follicular (3)  ·  Leiomyosarcoma (1)  ·  Lipoma (1)  ·  Liposarcoma (1)  ·  Pain, Postoperative (1)

Sponsors

Kythera Biopharmaceuticals (4)  ·  Allay Therapeutics, Inc. (1)  ·  Benjamin Izar (1)

Countries

Australia (3)  ·  Canada (3)  ·  United Kingdom (3)  ·  United States (3)

Top investigators

Benjamin Izar, MD (1)  ·  Frederick Beddingfield, III, M.D., Ph.D. (1)  ·  Frederick Beddingfield, MD, PhD (1)  ·  Frederick Beddingfield, MD. PhD (1)  ·  Patricia S. Walker, M.D., Ph.D. (1)

Results publications

PMID 34115682, PMID 39034053